Inhalable insulin has been developed.[114] The original products were withdrawn due to side effects.[114] Afrezza, under development by the pharmaceuticals company MannKind Corporation, was approved by the FDA for general sale in June 2014.[115] An advantage to inhaled insulin is that it may be more convenient and easy to use.[116]